Accuracy, feasibility and reliability of linac-based VMAT technique for total body irradiation (TBI)
Radiation therapy in the form of total body irradiation (TBI) technique continues to be an important part of conditioning regimens in patients undergoing bone-marrow transplantation in haematological ...
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Elekta (EKTA-B.ST) and Royal Philips (NYSE:PHG, AEX:PHIA) today announced the installation of a third high-field (1.5 Tesla) MR-guided linear accelerator ...
TOWNSVILLE, Australia, Dec. 10, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that Townsville Hospital in Queensland has treated the first patient in Australia using Elekta Unity MR-Linac, a ...
ATLANTA, July 19, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has achieved regulatory certification from the ...
SAN DIEGO, September 27, 2017 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company's transformative ...
STOCKHOLM, March 8, 2019 /PRNewswire/ -- With the number of new cancer cases globally expected to rise by about 70 percent over the next two decades1-2, access to radiotherapy – a key treatment ...
Elekta EKTAY recently announced that its Elekta Evo CT-Linac has received 510(k) clearance from the FDA, making the system available to radiation oncology professionals across the United States. Evo ...
Elekta AB received U.S. FDA clearance for what it called a “groundbreaking upgrade” of its MR-Linac platform which can continuously calculate the movement of a tumor anywhere in the body. The company ...
GUWAHATI, India, Dec. 5, 2025 /PRNewswire/ -- Elekta announced the introduction of its latest linear accelerator (linac), Evo*, to the Indian market. Already launched in Europe and other regions, Evo ...
Elekta EKTAY recently announced that its Elekta Evo CT-Linac has received 510(k) clearance from the FDA, making the system available to radiation oncology professionals across the United States. Evo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results